Yazar "Turkmen, A." için listeleme
-
COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul
Demir, E.; Uyar, M.; Parmaksiz, E.; Sinangil, A.; Yelken, B.; Dirim, A.B.; Turkmen, A. (Blackwell Publishing Inc., 2020)Introduction: Management of COVID-19 in kidney transplant recipients should include treatment of the infection, regulation of immunosuppression, and supportive therapy. However, there is no consensus on this issue yet. ... -
Human Leukocyte Antigen and Major Histocompatibility Complex Class I-Related Chain A Antibodies After Kidney Transplantation in Turkish Renal Transplant Recipients
Seyhun, Y.; Ozdilli, K.; Oguz, F.; Karahan, G.; Onal, E.; Turkmen, A.; Carin, M. (ELSEVIER SCIENCE INC, 2012)Background. This study was designed to determine whether human leukocyte antigen (HLA) and major histocompatibility complex class I chain-related A (MICA) antibody (Ab) production during the first 6 months posttransplantation ... -
Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant
Ciftci, H. S.; Demir, E.; Karadeniz, M. S.; Tefik, T.; Nane, I.; Oguz, F. S.; Turkmen, A. (TAYLOR & FRANCIS LTD, 2018)Background: There are differences in pharmacokinetic of mycophenolic acid among individuals. The UGT1A9 enzyme is of special interest since it is the main enzyme involved in the glucuronidation of MPA. Single nucleotide ...